North Georgia
Active member
- Joined
- Dec 31, 2022
- Messages
- 40
- Reason
- PALS
- Diagnosis
- 11/2022
- Country
- US
- State
- GA
- City
- Atlanta
New peer-reviewed research shows TikoMed’s ILB mobilizes and modulates key growth factors that trigger a cascade of neuroprotective mechanisms able to target all neuroinflammation-driven diseases including Amyotrophic Lateral Sclerosis
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate
The mechanism of action of a novel neuroprotective low molecular weight dextran sulphate
Last edited by a moderator:
